Does maternal serum screening for Down syndrome induce anxiety in younger mothers?

Singapore Medical Journal

Volumn 45, Issue 8, 2004, Pages 375-378

  Lai, Fon Min ^a,b,c   Ng, C C M ^a   Yeo, G S H ^a  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b Antenatal Risk Assessment Unit   (Singapore)

^c Camden Medical Centre   (Singapore)

Author keywords

Anxiety; Down syndrome; Maternal serum screening; State trait anxiety inventory

Indexed keywords

ADULT; ANXIETY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN SYNDROME; FEMALE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MATERNAL WELFARE; MEDICAL ASSESSMENT; NURSE; PEDIATRIC HOSPITAL; PREGNANCY; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; SERUM; SINGAPORE; SPEECH; STANDARD; STATISTICAL ANALYSIS; ULTRASOUND; VALIDATION PROCESS;

ADULT; ANXIETY; COUNSELING; DOWN SYNDROME; FEMALE; HUMANS; MANIFEST ANXIETY SCALE; MASS SCREENING; MATERNAL AGE; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS; TEST ANXIETY SCALE; ULTRASONOGRAPHY, PRENATAL;

EID: 4143086113     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Quagliarini D, Betti S, Brambati B, Nicolini U. Coping with serum screening for Down syndrome when the result is given as a numeric value. Prenat Diagn 1998; 18:816-21.
2. Marteau TM, Johnston M, Shaw RW, Michie S, Kidd J, New M. The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. J Psychosom 1989; 33:7-16.
3. Abuelo DN, Hopmann MR, Barsel-Bowers G, Goldstein A. Anxiety in women with low maternal serum alpha-fetoprotein screening results. Prenat Diagn 1991; 11:381-5.
4. Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F. Informed consent to serum screening for Down syndrome: are women given adequate information? Prenat Diagn 1999; 19:1-7.
5. Elias S, Simpson JL. Genetic counselling. In: Simpson JL, Elias S, eds. Essentials of Prenatal Diagnosis. New York: Churchill-Livingstone, 1993:3-13.
6. Vyas S. Screening for Down's syndrome. Br Med J 1994; 309:753-4.
7. Searle J. Fearing the worst - why do pregnant women feel "at risk"? Aust N Z J Obstet Gynaecol 1996; 36:279-86.
8. Spielberger CS, Gorsuch RL, Lushene RE. The State Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press, 1970.
9. Johnson RA, Wichern DW. Applied Multivariate Statistical Analysis. New Jersey: Prentice-Hall, 2002; 210-71.
10. Cheung YB, Khoo KS, Karlberg J, Machin D. Association between psychological symptoms in adults and growth in early life: longitudinal follow-up study. Br Med J 2002; 325:749-51.
11. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. Chichester: Wiley, 2000.
12. Weinans MJ, Huijssoon AM, Tymstra T, Gerrits MC, Beekhuis JR, Mantingh A. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy. Prenat Diagn 2000; 20:705-8.
13. Marteau TM, Cook R, Kidd J, Michie S, Johnston M, Slack J, et al. The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn 1992; 12:205-14.
14. Marteau TM, Slack J. Psychological implications of prenatal diagnosis for patients and health professionals. In: Brock DJH, Rodeck CH, Ferguson-Smith MA, eds. Prenatal Diagnosis and Screening. Edinburgh: Churchill-Livingstone, 1992; 663-73.
15. Ng CCM, Lai FM, Yeo GSH. Assessment of maternal anxiety levels before and after amniocentesis. Singapore Med J 2004; 45:370-4.
16. Chua Y, Lai FM, Yeo GSH. Reasons for low uptake of amniocentesis in a multi-ethnic population. In: Ben-Rafael, Shoham Z, Frydman R, eds. Second World Congress on Controversies in Obstetrics Gynaecology & Infertility Vol II Paris (France): Monduzzi Editore SpA, Sept 6-9 2001; 7-12.